Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 8.828.92-0.030.06-0.07

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is 8.82 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20258.82
Mar20248.92
Mar2023-0.03
Mar20220.06
Mar2021-0.07

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2025 8.82
-1.12
Mar2024 8.92
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,302.2 Cr 1.5% -3.5% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,872.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,706.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹127,449.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,125.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹104,827.0 Cr -0.5% -4.2% -6.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-3.5%

-10.6%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses